These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22688827)

  • 1. Resumption of ovarian function after 4 years of estro-progestin treatment in a young woman with Crohn's disease and premature ovarian insufficiency: a case report.
    Caroppo E; D'Amato G
    J Assist Reprod Genet; 2012 Sep; 29(9):973-7. PubMed ID: 22688827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does gonadotropin suppression result in follicular development in premature ovarian failure?
    Buckler HM; Healy DL; Burger HG
    Gynecol Endocrinol; 1993 Jun; 7(2):123-8. PubMed ID: 8213226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnancy despite imminent ovarian failure and extremely high endogenous gonadotropins and therapeutic strategies: case report and review.
    Check ML; Check JH; Kaplan H
    Clin Exp Obstet Gynecol; 2004; 31(4):299-301. PubMed ID: 15672973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of levonorgestrel-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use.
    Xiao B; Zeng T; Wu S; Sun H; Xiao N
    Contraception; 1995 Jun; 51(6):359-65. PubMed ID: 7554977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG; Steffens D; Schramm G
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
    Buckler HM; Evans CA; Mamtora H; Burger HG; Anderson DC
    J Clin Endocrinol Metab; 1991 Jan; 72(1):116-24. PubMed ID: 1824706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous Recovery of Ovarian Function in an Adolescent with Galactosemia and Apparent Premature Ovarian Insufficiency.
    Davies P; Connor E; MacKenzie J; Jamieson MA
    J Pediatr Adolesc Gynecol; 2015 Aug; 28(4):e101-3. PubMed ID: 26024933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D; Smith S; Zacur H
    Contraception; 1995 Aug; 52(2):105-9. PubMed ID: 8536446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of action of a new low-dosed combined oral contraceptive.
    Dericks-Tan JS; Schneider K; Taubert HD
    Arch Gynecol; 1980; 229(2):107-14. PubMed ID: 6768343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of deliberate omission of Trinordiol or Microgynon on the hypothalamo-pituitary-ovarian axis.
    Smith SK; Kirkman RJ; Arce BB; McNeilly AS; Loudon NB; Baird DT
    Contraception; 1986 Nov; 34(5):513-22. PubMed ID: 3102162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of luteinized graafian follicles in patients with karyotypically normal spontaneous premature ovarian failure.
    Nelson LM; Anasti JN; Kimzey LM; Defensor RA; Lipetz KJ; White BJ; Shawker TH; Merino MJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1470-5. PubMed ID: 7962345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the pituitary-ovarian axis in the pill-free interval during use of low-dose combined oral contraceptives.
    van Heusden AM; Fauser BC
    Contraception; 1999 Apr; 59(4):237-43. PubMed ID: 10457868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected pregnancy during hormone-replacement therapy in a woman with elevated follicle-stimulating hormone levels and amenorrhea.
    Laml T; Huber JC; Albrecht AE; Sintenis WA; Hartmann BW
    Gynecol Endocrinol; 1999 Apr; 13(2):89-92. PubMed ID: 10399052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women.
    Zinaman MJ; Cartledge T; Tomai T; Tippett P; Merriam GR
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2088-93. PubMed ID: 7608260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shorter pill-free interval in combined oral contraceptives decreases follicular development.
    Spona J; Elstein M; Feichtinger W; Sullivan H; Lüdicke F; Müller U; Düsterberg B
    Contraception; 1996 Aug; 54(2):71-7. PubMed ID: 8842582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.